IGC Pharma (IGC) Inventory (2011 - 2026)

IGC Pharma (IGC) has reported Inventory for 15 consecutive years, with $638000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Inventory fell 53.09% year-over-year to $638000.0 in Q1 2026; TTM through Mar 2026 was $638000.0, a 53.09% decrease from a year earlier, with the FY2026 full-year figure at $638000.0, down 53.09% from the prior year.
• Inventory was $638000.0 for Q1 2026 at IGC Pharma, roughly flat from $640000.0 in the prior quarter.
• Over five years, Inventory peaked at $3.8 million in Q3 2022 and troughed at $638000.0 in Q1 2026.
• A 5-year average of $2.1 million and a median of $1.5 million in 2024 frame the typical range for Inventory.
• The widest YoY moves for Inventory: up 10.66% in 2025, down 56.42% in 2025.
• Over 5 years, Inventory stood at $3.7 million in 2022, then slumped by 48.64% to $1.9 million in 2023, then slipped by 25.56% to $1.4 million in 2024, then plunged by 55.34% to $640000.0 in 2025, then slipped by 0.31% to $638000.0 in 2026.
• The last three Inventory figures came in at $638000.0 (Q1 2026), $640000.0 (Q4 2025), and $658000.0 (Q3 2025), per Business Quant data.